Search

everythinglearnresearchcommunity

for

Search:↓

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Laser therapy effectively treats all stages of hidradenitis suppurativa, offering a reliable alternative to medication.

The new drug carriers show promise for better targeting and treating ovarian cancer.

The new gel improves treatment of tough skin infections.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Combining exosomes with nanoparticles speeds up healing of diabetic pressure ulcers.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Low-dose methotrexate, combined with surgical and local treatments, effectively treats severe vulvovaginal lichen planus.

Phytosome technology improves the absorption and effectiveness of citrus flavonoids.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Nanospanlastics are effective in targeted drug delivery for chronic diseases, improving skin conditions, treating hair loss, and increasing drug absorption.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Improved delivery systems can enhance oleanolic acid's effectiveness in treating various conditions.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Baicalin may help treat severe drug-induced skin reactions.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Improved tablets lead to faster, better drug absorption for hair loss treatment.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

It's unclear if cell-based therapies from lipoaspirate devices improve clinical outcomes due to inconsistent data.